单细胞RNA测序和免疫微环境分析揭示了子宫癌中PLOD2驱动的恶性转变
Zhiheng Lin1, Fengxin Wang2, Renwu Yin3
1Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Frontiers in immunology
|January 22, 2025
概括
这项研究确定了8种细胞类型和5种恶性宫癌上皮细胞 (EPC) 亚种群. 一个新的风险评分模型强调NNMT+CAEPCs作为治疗目标,与免疫逃避和宫癌的不良结果相关.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 宫癌是全球女性癌症死亡的主要原因,主要是由持续的人类乳头瘤病毒 (HPV) 感染引起的.
- 尽管查和治疗方面取得了进展,但宫癌仍然是一个重大的健康挑战,特别是在低收入和中等收入国家.
- 了解瘤微环境对于识别晚期宫癌的新疗法目标至关重要.
研究的目的:
- 为了研究晚期宫癌的细胞组成和免疫微环境.
- 确定驱动瘤进展和分化的主要细胞类型和亚群.
- 开发一个预后模型,并确定宫癌的潜在治疗点.
主要方法:
- 利用大量和单细胞RNA测序数据用于使用Seurat的细胞类型识别和聚类.
- 进行丰富分析和差异基因表达,以确定功能途径.
- 使用CIBERSORT和ESTIMATE进行免疫微环境分析,以及Cox回归用于预后特征提取.
- 评估药物敏感性,并对预后基因进行了体外验证.
主要成果:
- 确定了八种不同的细胞类型,其中宫癌上皮细胞 (EPC) 呈现出高增殖率和干性.
- 定义了五个EPC亚群,其中C1 NNMT+ CAEPC被确定为瘤分化的关键驱动因素.
- 开发了一个NNMT CAEPCs风险评分 (NCRS) 模型,证明高NCRS和免疫逃避之间的相关性,表明患者的不良结果.
- 验证了PLOD2作为预后基因,显著促进子宫癌细胞的增殖,迁移和入侵.
结论:
- 在宫癌中界定了八种细胞类型和五种恶性EPC亚群,确定C1 NNMT + CAEPCs作为关键的治疗标.
- 该NCRS模型显示出预后能力,较高的得分与较差的临床结果有关.
- 验证了PLOD2作为预后基因的作用,强调了其治疗潜力以及需要综合免疫疗法和向治疗以改善宫癌管理的需要.
相关概念视频
03:18Non-LTR Retrotransposons
12.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.5K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
01:06Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K